Gilead Sciences, Inc. (GILD)

bluebird bio Market Cap

Gilead Sciences has a market cap or net worth of $148.16 billion as of August 8, 2025. Its market cap has increased by 61.80% in one year.

• Market Cap: 148.16B
• Enterprise Value: 165.14B
• 1-Year Change: 61.80%
• Ranking: #90
• Category: Large-Cap
• Stock Price: $119.41

Market Cap Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $148.16B, an increase of 15,126.06%. That is a compound annual growth rate of 20.71%.

Market Cap History

Date	Market Cap	% Change
Aug 8, 2025	148.16B	28.71%
Dec 31, 2024	115.12B	14.04%
Dec 29, 2023	100.94B	-6.25%
Dec 30, 2022	107.68B	18.22%
Dec 31, 2021	91.08B	24.72%
Dec 31, 2020	73.03B	-11.17%
Dec 31, 2019	82.21B	1.60%
Dec 31, 2018	80.92B	-13.53%
Dec 29, 2017	93.58B	-0.81%
Dec 30, 2016	94.34B	-35.31%
Dec 31, 2015	145.83B	2.55%
Dec 31, 2014	142.21B	23.49%
Dec 31, 2013	115.15B	106.93%
Dec 31, 2012	55.65B	81.01%
Dec 30, 2011	30.74B	4.49%
Dec 31, 2010	29.42B	-24.44%
Dec 31, 2009	38.94B	-16.37%
Dec 31, 2008	46.56B	8.73%
Dec 31, 2007	42.82B	43.43%
Dec 29, 2006	29.86B	24.03%
Dec 30, 2005	24.07B	58.92%
Dec 31, 2004	15.15B	28.36%
Dec 31, 2003	11.80B	76.49%
Dec 31, 2002	6.69B	6.07%
Dec 31, 2001	6.30B	61.59%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	568.49B
Johnson & Johnson	418.09B
AbbVie	352.46B
Abbott Laboratories	234.21B
AstraZeneca	227.78B
UnitedHealth Group	226.17B
Novartis AG	225.61B
Novo Nordisk	213.92B